/ Print /

Health Management

Five factors driving up the cost of oncology drugsThe high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
Four reasons COPD patients don’t receive the right treatmentsMany providers are overlooking important steps that can help guide proper COPD treatment and therefore, reduce admissions and readmissions.
Six things to know about CMS' new bundled payment modelCMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Trump’s impact on ACA enrollment: What you need to knowHow did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.
Most employees unsatisfied with employers' well-being programsWillis Towers Watson research finds a dramatic increase among employers seeking to differentiate their health and well-being programs for competitive advantage.
Three ways healthcare executives can uncover consumers at risk for fluWith influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
CAR T-cell therapies in treating lymphoma: Pros and consCatherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Expansion of association health plans: 6 things to know about Trump’s proposalTrump’s new proposal would broaden access to association health plans. Here’s six things to know.
End-of-life care planning advancements: What health execs should knowMore awareness and new state laws regarding end-of-life treatment are affecting treatment approaches. Here’s what you need to know.
Five changes healthcare executives can expect in 2018The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.